21.48
3.87%
0.80
시장 영업 전:
21.37
-0.11
-0.51%
전일 마감가:
$20.68
열려 있는:
$20.59
하루 거래량:
396.60K
Relative Volume:
2.25
시가총액:
$870.02M
수익:
$982.01M
순이익/손실:
$14.80M
주가수익비율:
58.05
EPS:
0.37
순현금흐름:
$37.02M
1주 성능:
+3.62%
1개월 성능:
-7.89%
6개월 성능:
+25.32%
1년 성능:
+90.93%
Phibro Animal Health Corp Stock (PAHC) Company Profile
명칭
Phibro Animal Health Corp
전화
201-329-7300
주소
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
PAHC을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
21.48 | 870.02M | 982.01M | 14.80M | 37.02M | 0.37 |
ZTS
Zoetis Inc
|
165.02 | 74.45B | 9.15B | 2.43B | 2.31B | 5.32 |
HLN
Haleon Plc Adr
|
9.49 | 42.91B | 14.26B | 1.55B | 0 | 0.3383 |
TAK
Takeda Pharmaceutical Co Adr
|
13.24 | 41.98B | 30.27B | 1.93B | 3.45B | 0.6044 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.49 | 24.35B | 16.77B | -959.00M | 1.37B | -0.85 |
VTRS
Viatris Inc
|
11.96 | 14.28B | 15.05B | -883.30M | 1.89B | -0.74 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-09-10 | 개시 | JP Morgan | Neutral |
2023-12-07 | 개시 | Exane BNP Paribas | Underperform |
2022-12-21 | 개시 | ROTH Capital | Buy |
2022-07-25 | 다운그레이드 | Barclays | Equal Weight → Underweight |
2022-01-10 | 업그레이드 | Barclays | Underweight → Equal Weight |
2021-11-18 | 개시 | Morgan Stanley | Equal-Weight |
2021-08-05 | 재개 | Credit Suisse | Neutral |
2021-07-07 | 다운그레이드 | Barclays | Equal Weight → Underweight |
2020-08-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
2020-02-06 | 다운그레이드 | Gabelli & Co | Buy → Hold |
2020-01-28 | 업그레이드 | Barclays | Underweight → Equal Weight |
2019-09-05 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
2019-08-29 | 재확인 | BofA/Merrill | Underperform |
2019-06-11 | 개시 | Barclays | Underweight |
2019-05-23 | 개시 | Guggenheim | Neutral |
2019-05-09 | 업그레이드 | Gabelli & Co | Hold → Buy |
2017-08-23 | 재개 | BofA/Merrill | Underperform |
2017-06-02 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
2016-12-15 | 개시 | Piper Jaffray | Overweight |
2016-11-11 | 다운그레이드 | Macquarie | Neutral → Underperform |
2016-11-10 | 다운그레이드 | Gabelli & Co | Buy → Hold |
2016-04-11 | 재확인 | Guggenheim | Buy |
2016-02-04 | 개시 | Credit Suisse | Outperform |
2016-01-15 | 다운그레이드 | Barclays | Overweight → Underweight |
2015-09-30 | 개시 | Gabelli & Co | Buy |
2015-04-24 | 재확인 | Barclays | Overweight |
2015-04-21 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
2014-05-06 | 개시 | Barclays | Overweight |
모두보기
Phibro Animal Health Corp 주식(PAHC)의 최신 뉴스
Zacks Research Issues Optimistic Forecast for PAHC Earnings - MarketBeat
Expanding Global Network, Vaccine Sales Support PAHC Stock - Yahoo Finance
Zacks Research Has Positive Forecast for PAHC Q2 Earnings - MarketBeat
Phibro Animal Health (NASDAQ:PAHC) Sees Strong Trading VolumeStill a Buy? - MarketBeat
3 Reasons Growth Investors Will Love Phibro (PAHC) - Yahoo Finance Australia
Growth Trends in the Porcine Vaccines Market, Forecast to 2028: Increasing Government Initiatives for Funding Animal Husbandry - GlobeNewswire Inc.
Is Phibro Animal Health (PAHC) a Great Value Stock Right Now? - Yahoo Finance
Phibro Animal Health Co. (NASDAQ:PAHC) Shares Sold by Principal Financial Group Inc. - Defense World
Phibro Animal Health (NASDAQ:PAHC) Raised to Strong-Buy at StockNews.com - Defense World
Phibro Animal Health Gains 83% in a Year: What's Driving the Stock? - MSN
Reasons to Retain Phibro Stock in Your Portfolio Now - MSN
Geode Capital Management LLC Has $11.43 Million Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - MarketBeat
Sanctuary Advisors LLC Has $279,000 Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - MSN
Phibro Animal Health (NASDAQ:PAHC) Downgraded by StockNews.com to “Buy” - Defense World
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock - Yahoo Finance
Limoneira And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
State Street Corp Sells 33,324 Shares of Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Barclays PLC Purchases 29,271 Shares of Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Phibro Animal Health Co. (NASDAQ:PAHC) Shares Sold by State Street Corp - MarketBeat
Wellington Management Group LLP Trims Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Morgan Stanley Issues Positive Forecast for Phibro Animal Health (NASDAQ:PAHC) Stock Price - MarketBeat
Phibro Animal Health Co. (NASDAQ:PAHC) Shares Bought by Fmr LLC - Defense World
BNP Paribas Financial Markets Grows Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Zacks Research Analysts Boost Earnings Estimates for PAHC - Defense World
Zacks Research Brokers Increase Earnings Estimates for PAHC - MarketBeat
Equities Analysts Set Expectations for PAHC FY2025 Earnings - MarketBeat
Global Veterinary Vaccines Market is Predicted to Cross USD 16 Billion by 2030 | DelveInsight - The Malaysian Reserve
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) Stock Rating Lowered by StockNews.com - MarketBeat
Villanova Investment Management Co LLC Sells 31,210 Shares of Phibro Animal Health Co. (NASDAQ:PAHC) - MarketBeat
Phibro (PAHC) Down 2.5% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Zacks Industry Outlook Highlights ResMed, Haemonetics, Phibro and Agios - Yahoo Finance
Reasons to Add Phibro Stock to Your Portfolio Right Now - Yahoo Finance
What is Zacks Research's Forecast for PAHC Q1 Earnings? - MarketBeat
Here is Why Growth Investors Should Buy Phibro (PAHC) Now - Yahoo Finance
Phibro Animal Health Co. (NASDAQ:PAHC) Stock Holdings Lifted by Algert Global LLC - MarketBeat
Phibro Animal Health (NASDAQ:PAHC) Stock Rating Upgraded by StockNews.com - MarketBeat
PAHC (Phibro Animal Health) 5-Year Dividend Growth Rate : 0.60% (As of Sep. 2024) - GuruFocus.com
PAHC (Phibro Animal Health) Free Cash Flow per Share : $1.00 (TTM As of Sep. 2024) - GuruFocus.com
PAHC (Phibro Animal Health) Effective Interest Rate on Debt % : 6.30% (As of Sep. 2024) - GuruFocus.com
Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term - Yahoo Finance
PAHC (Phibro Animal Health) EPS without NRI : $1.40 (TTM As of Sep. 2024) - GuruFocus.com
U.S. Animal Health Market Size, Share | Industry Report 2030 - Grand View Research
Zacks Research Has Pessimistic Outlook of PAHC Q3 Earnings - MarketBeat
PAHC (Phibro Animal Health) 50-Day SMA : $23.16 (As of Nov. 24, 2024) - GuruFocus.com
Atria Investments Inc Has $283,000 Position in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
PAHC (Phibro Animal Health) FCF Margin % : 1.17% (As of Sep. 2024) - GuruFocus.com
Zacks Research Has Pessimistic Outlook of PAHC Q2 Earnings - MarketBeat
Phibro Animal Health (NASDAQ:PAHC) Lowered to Buy Rating by StockNews.com - MarketBeat
Phibro Animal Health (NASDAQ:PAHC) Rating Lowered to Buy at StockNews.com - Defense World
Phibro Animal Health Corp (PAHC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):